Maravai LifeSciences Holdings, Inc. Class A Common Stock
$7.27
$0.43 (+6.29%)
$6.98Day Range$7.51
Key Statistics
Market Cap
$1.08B
Shares Outstanding
149.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 20, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$6.98
Day High
$7.51
Day Low
$6.98
Volume
3.45M
VWAP
$7.31
Prev Close
$6.84
Transactions
--
Acc. Volume
--
About Maravai LifeSciences Holdings, Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
PHARMACEUTICAL PREPARATIONSSIC 2834415 employees10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO, CA, 92121(858) 546-0004IPO Nov 20, 2020US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001823239
- Composite FIGI
- BBG00Y1DFV91
- Share Class FIGI
- BBG00Y1DFW44
- Ticker Root
- MRVI
- SIC Code
- 2834
About Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) Stock
Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) closed the 2026-09-17 session at $7.27, up 6.29% versus the previous close (+0.43). The stock opened at $6.98 and traded between $6.98 and $7.51 during that session. Session trading volume was 3.4M shares. The volume-weighted average price (VWAP) is $7.31.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Maravai LifeSciences Holdings, Inc. Class A Common Stock has a market capitalization of $1.08 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. MRVI is listed on the XNAS exchange. The company employs approximately 415 people. Maravai LifeSciences Holdings, Inc. Class A Common Stock is headquartered in SAN DIEGO, CA. The recorded listing date is 2020-11-20.
On this page you can find market MRVI stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.